CureVac $450 million public offering
We advised CureVac on the equity offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Seer $251.3 million stock offering
We advised the underwriters on the SEC-registered equity offering
Surgalign Holdings $37.5 million follow-on offering
We advised the underwriters on the equity offering
Personalis, Inc. $150 million stock offering
We advised the underwriters on the equity offering
Precigen $129 million common stock offering
We advised the underwriters in connection with the SEC-registered equity offering
Cryoport $287.5 million follow-on offering
We advised the underwriters on the SEC-registered offering
CytomX Therapeutics $100 million follow-on offering
We advised the joint book-running managers in connection with the equity offering
Editas Medicine $231 million stock offering
We advised the joint book-running managers in connection with the equity offering
Innovent Biologics HK$4.73 billion placement of shares
We advised the joint placing agents in connection with the equity offering
IDEAYA Biosciences $90 million at-the-market offering
We advised the sales agent on the SEC-registered equity offering